Over
the last few decades, anticancer peptides (ACPs) have turned
into potential warheads against cancer. Apart from small molecules
and monoclonal antibodies, ACPs have been proven to be effective against
cancer cells. ACPs are small cationic peptides that selectively bind
to the negatively charged cancer cell membrane and kill them by various
mechanisms. In the present study, we prepared a random scrambled library
of 1200 peptides from the 100 known ACPs and virtually screened them
for their anticancer properties. From in silico-predicted ACPs, 27
peptides were prioritized based on their support vector machine (SVM)
score. Based on the SVM score and properties such as hydrophobicity,
size, overall net charge, secondary structure, and synthetic feasibility,
finally, four peptides were synthesized and screened for their biological
activities. Cancer cell membrane-deforming potential of two most active
peptides, peptide1 and peptide2 was assessed with molecular dynamics
simulation. We found that peptide1 remains adsorbed to the membrane
surface, while peptide2 has membrane penetration capability. The present
study will be helpful in the computational design of ACPs and understanding
their interaction with the cancerous cell’s membrane.
The histamine 3 receptor (H3R) is a presynaptic receptor, which modulates several neurotransmitters including histamine and various essential physiological processes, such as feeding, arousal, cognition, and pain. The H3R is considered as a drug target for the treatment of several central nervous system disorders. We have synthesized and identified a novel series of 4-aryl-6-methyl-5,6,7,8tetrahydroquinazolinamines that act as selective H3R antagonists. Among all the synthesized compounds, in vitro and docking studies suggested that the 4-methoxy-phenyl-substituted tetrahydroquinazolinamine compound 4c has potent and selective H3R antagonist activity (IC 50 < 0.04 μM). Compound 4c did not exhibit any activity on the hERG ion channel and pan-assay interference compounds liability. Pharmacokinetic studies showed that 4c crosses the blood brain barrier, and in vivo studies demonstrated that 4c induces anorexia and weight loss in obese, but not in lean mice. These data reveal the therapeutic potential of 4c as an anti-obesity candidate drug via antagonizing the H3R.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.